AptarGroup, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
April 26, 2024 at 02:55 am IST
Share
AptarGroup, Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was USD 915.45 million compared to USD 860.07 million a year ago. Net income was USD 83.1 million compared to USD 54.76 million a year ago.
Basic earnings per share from continuing operations was USD 1.26 compared to USD 0.84 a year ago. Diluted earnings per share from continuing operations was USD 1.23 compared to USD 0.82 a year ago.
AptarGroup, Inc. is engaged in designing and manufacturing of drug and consumer product dosing, dispensing and protection technologies. The Company serves various end markets, including pharmaceutical, beauty, food, beverage, personal care and home care. The Company operates through three segments: Aptar Pharma, Aptar Beauty and Aptar Closures. Aptar Pharma segment supplies nasal drug delivery spray pumps and metered dose inhaler valves (MDIs) to the pharmaceutical and healthcare markets worldwide and supplies elastomer for injectable primary packaging components worldwide. The segment also provides services designed to accelerate and de-risk the development and regulatory approvals of drugs using drug delivery devices. The Aptar Beauty segment sells a variety of pumps, airless systems and valves to the fragrance, color cosmetics, facial skincare, personal care and home care markets. Aptar Closures segment primarily sells dispensing closures.
APTARGROUP, INC. 